Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects
NCT06787781
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Metabolic Evaluation
Cardiac Complications
Interventions
DRUG:
Alpha Lipoic Acid
Sponsor
University of Messina